SEC Form 4 · accession 0001127602-17-022461
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Louis W Sullivan
Director
Period of report
Jun 28, 2017
Accepted (ET)
Jun 30, 2017 · 4:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F1,F3 | $0.00 | Jun 28, 2017 | A | 1,620 | A | — | — | Common Stock | 1,620 | 1,620 | D |
| Stock OptionsF2,F4 | $132.30 | Jun 28, 2017 | A | 4,210 | A | Jun 28, 2018 | Jun 28, 2027 | Common Stock | 4,210 | 4,210 | D |
Explanation of responses
- F1Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
- F2Annual non-employee director grant of restricted stock units and/or stock options, which are awarded and priced each year on the date of the issuer's Annual Meeting of Shareholders.
- F3The restricted stock units vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Shares will be issued to the reporting person upon vesting unless the reporting person has elected to defer receipt of shares.
- F4Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.